Combination Therapy With The Akt Inhibitor, Ipatasertib, Endocrine Therapy, And A Cdk4/6 Inhibitor For Hormone Receptor Positive (Hr+)/Her2 Negative Metastatic Breast Cancer (Mbc): Results From The Phase I Taktic Trial
Ipatasertib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Combination Therapy With The Akt Inhibitor, Ipatasertib, Endocrine Therapy, And A Cdk4/6 Inhibitor For Hormone Receptor Positive (Hr+)/Her2 Negative Metastatic Breast Cancer (Mbc): Results From The Phase I Taktic Trial ### Output: Ipatasertib